Trademark Overview
On Wednesday, March 8, 2000, a trademark application was filed for ANDNA with the United States Patent and Trademark Office. The USPTO has given the ANDNA trademark a serial number of 75938115. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, September 20, 2002. This trademark is owned by NYCOMED AMERSHAM PLC.. The ANDNA trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:
Chemicals, biochemicals and reagents, namely, nucleotides, fluorescent nucleotides, oligonucleotides, peptides, proteins, amino acids, organic molecules, markers for DNA/RNA synthesis; reagents for luminescence; reagents for gene expression quantification; reagents for use with the polymerase chain reaction, PCR, process and the rolling circle amplification, RCA, process; reagents for cDNA cloning vectors, modifying and restriction enzymes; reagents for labeling, sequencing and fragment analysis of nucleic acids, proteins and custom synthesis; reagents for recombinant protein expression purification, chromatography media; electrophoresis; spectrophotometry and fluorometry; radiochemicals; scintillation assays; and high through put screening assays for drug development; and chemical preparations and substances for use in the manufacture of pharmaceutical products; diagnostic preparations and substances; chemical test reagents saline solution and reagent-coated paper all for scientific a...
Contrast media for medical imaging; diagnostic scanning agents for in vivo use; radiopharmaceutical products for clinical, medical, scientific, and research use; radioactive sources and standards for use in nuclear medicine; radioactive pharmaceutical preparations and non-radioactive reagents for producing radiopharmaceuticals for in vivo diagnostic or therapeutic use; pharmaceutical preparations for use in spin signal diagnosis; pre-filled vials containing medical diagnostic reagents; pre-filled cartridges containing saline solution
Scientific apparatus and instruments used for radiology for the purpose of measuring, monitoring and surveying; computers, printers, and software programs used for the purpose of life science research; radiology apparatus and instruments for the reading and interpretation of autoradiographs and films including automated film readers and scanners; apparatus for electrophoresis; chromatography columns and pumps; apparatus for microfabrication; apparatus for scintillation; imaging apparatus for radioactive and luminescent emissions; synthesis and purification integrated systems for use in radiology; apparatus manufacturing oligonucleotides; apparatus for microarrays; microarray slides; glassware; vials and microvials; microtitre plates; and parts and fittings for the aforesaid goods
Surgical and medical apparatus and instruments used for the purpose of measuring, monitoring and surveying in the field of radio therapy, comprised of medical needles, suture needles, implantable radiation therapy devices consisting of encapsulated radioisotope brachytherapy sources, radiation therapy delivery system consisting primarily of radioactive seeds and a bio-absorbable carrier assembly; magnetic resonance imagers, MRI; x-ray apparatus for medical use; x-ray diagnostic apparatus, computerized tomography, CAT, scanners and ultrasound imagers; radiological apparatus for diagnostic and medical purposes; test kits for clinical medical use comprised of test tubes, test plates and indicator charts for evaluating test results; vials; cannulas; vials access cannulas; syringes; injectors; cartridges; infusion pumps for intravenous administration of fluids; needles for medical purposes and parts and fittings for the aforesaid goods
Advisory services for pharmaceutical companies in the field of purification and chromatography research and development services in the field of pharmaceutical and life sciences; high through put screening assays for drug development services; customer synthesis services consisting of isotopically labelling chemical biological molecules; and analytical services in the chemical analytical field, the diagnostic field, and the medical imaging field